Supernus Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-55.6353.4610.318.57
Price/Sales ratio
3.503.152.802.61
Earnings per Share (EPS)
$-0.74$0.77$3.99$4.8

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
17.6545.5313.6935.3015.5610.9910.4228.9831.531.19K32.8215.56
Price/Sales ratio
2.874.415.816.694.223.162.542.672.862.592.983.16
Price/Book Value ratio
4.915.366.517.563.812.081.771.892.161.712.242.24
Price/Cash Flow ratio
45.3519.8618.6917.6413.388.689.5612.1716.3814.2017.0513.38
Price/Free Cash Flow ratio
49.1221.2519.1517.9613.478.859.8012.3716.4414.2717.1113.47
Price/Earnings Growth ratio
-0.15-1.180.02-0.910.177.800.90-0.492.65-12.252.870.17
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
95.28%94.16%94.42%94.96%96.24%95.75%89.91%87.05%86.92%86.20%86.92%95.75%
Operating Profit Margin
19.85%12.23%25.21%32.93%35.32%37.82%33.37%14.83%10.08%-0.86%6.55%37.82%
Pretax Profit Margin
16.28%10.36%23.42%33.29%34.28%37.55%32.40%12.62%9.10%0.45%9.10%37.55%
Net Profit Margin
16.28%9.70%42.42%18.95%27.14%28.78%24.39%9.21%9.09%0.21%9.09%28.78%
Effective Tax Rate
20.30%6.38%-81.10%43.06%20.81%23.34%24.72%26.99%0.05%52.47%0.05%23.34%
Return on Assets
14.45%7.42%29.46%13.49%11.35%9.74%8.44%3.16%3.56%0.10%3.56%9.74%
Return On Equity
27.84%11.79%47.57%21.41%24.50%18.98%17.04%6.54%6.85%0.14%7.12%18.98%
Return on Capital Employed
22.02%13.31%23.69%33.01%17.69%14.86%13.79%6.26%6.63%-0.53%4.30%14.86%
Liquidity Ratios
Current Ratio
3.961.881.871.853.052.942.57N/AN/AN/A1.062.94
Quick Ratio
3.471.661.661.722.892.772.371.630.931.430.912.77
Cash ratio
2.701.101.110.811.191.121.170.640.130.250.131.12
Days of Sales Outstanding
51.6465.4770.4979.2091.8781.1698.8093.7690.5386.6090.5381.16
Days of Inventory outstanding
852.02545.44511.62391.12609.89583.38336.23417.99383.07337.24383.07583.38
Operating Cycle
903.67610.91582.12470.32701.76664.54435.04511.75473.61423.85405.40664.54
Days of Payables Outstanding
118.09186.94245.29164.1875.94222.1742.7645.3744.128.55403.1675.94
Cash Conversion Cycle
785.57423.97336.83306.14625.82442.37392.27466.38429.49415.29-218.17442.37
Debt Ratios
Debt Ratio
0.190.040.010.060.330.300.250.220.23N/A0.470.33
Debt Equity Ratio
0.370.060.020.090.730.580.510.470.45N/A0.920.73
Long-term Debt to Capitalization
0.270.050.020.070.420.360.330.31N/AN/A0.030.36
Total Debt to Capitalization
0.270.050.020.090.420.360.330.320.31N/A0.330.36
Interest Coverage Ratio
4.8814.3710.6463.487.976.547.39N/AN/AN/A6.186.54
Cash Flow to Debt Ratio
0.284.2316.044.310.380.410.360.320.29N/A0.260.41
Company Equity Multiplier
1.921.581.611.582.151.942.012.071.921.381.921.94
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.060.220.310.370.310.360.260.210.170.180.170.36
Free Cash Flow / Operating Cash Flow Ratio
0.920.930.970.980.990.980.970.980.990.990.990.99
Cash Flow Coverage Ratio
0.284.2316.044.310.380.410.360.320.29N/A0.260.41
Short Term Coverage Ratio
N/A64.63N/A26.7659.0844.1226.0017.540.29N/A0.2944.12
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A